VACCINES FOR ADULTS 2022-2023

Contract Award won by MERCK SHARP & DOHME LLC
No current value reported
RecipientMERCK SHARP & DOHME LLC UEI FCFDA78HKKG2
Award ID75D30122D14072
Award amountNo current value reported
Award type—
Awarding agencyDepartment of Health and Human Services — Centers for Disease Control and Prevention
NAICS325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC6505
Set-asideUnrestricted
Start dateJul 1, 2022
End date—
Place of performance—
Record updatedAug 18, 2022

View the official award record

More awards won by MERCK SHARP & DOHME LLC

COVID-19 ORAL ANTIVIRAL MK-4482 (MOLNUPIRAVIR)
Department of Defense · $2,205,000,834 · Jun 7, 2021
IGF::OT::IGF
Department of Health and Human Services · $236,307,634 · Sep 28, 2017
ERVEBO PROCUREMENT
Department of Health and Human Services · $156,033,983 · Sep 30, 2024
ADDRESSING THE COVID-19 PANDEMIC: URGENT PRIORITIES
Department of Health and Human Services · $102,299,549 · Mar 1, 2021
BPS - ADVANCE THE DEVELOPMENT OF V920, A VACCINE AGAINST EBOLA VIRUS USING A RECOMBINANT VESICULAR STOMATITIS VIRUS VECTOR. IGF::OT::IGF
Department of Health and Human Services · $65,103,309 · Aug 29, 2016

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids